119 related articles for article (PubMed ID: 23172093)
1. [Reversible encephalopathy caused by valproic acid in an adolescent with idiopathic generalised epilepsy].
Raspall-Chaure M; Lainez E; Toledo M; Salas-Puig J; Macaya-Ruiz A; Roig-Quilis M
Rev Neurol; 2012 Dec; 55(11):663-8. PubMed ID: 23172093
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
[TBL] [Abstract][Full Text] [Related]
3. [Hyperammonemic encephalopathy associated with valproate acid].
Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
[TBL] [Abstract][Full Text] [Related]
4. Encephalopathy induced by levetiracetam added to valproate.
Bauer J
Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
[TBL] [Abstract][Full Text] [Related]
5. [Encephalopathies caused by valproate].
Göbel R; Görtzen A; Bräunig P
Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
[TBL] [Abstract][Full Text] [Related]
6. [The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy].
Schmidt A; Darius J; Brosz M; Roth N; Meyer FP; Kroker S; Wien F; Brett B
Z Kinder Jugendpsychiatr; 1995 Sep; 23(3):161-70. PubMed ID: 7571875
[TBL] [Abstract][Full Text] [Related]
7. [Hyperammonaemic encephalopathy due to valproic acid].
Durán-Ferreras E; Jiménez-Vilches PL; Galá-Barranco JM; Fernández-Bolaños Porras R
Rev Neurol; 2008 May 1-15; 46(9):537-9. PubMed ID: 18446695
[TBL] [Abstract][Full Text] [Related]
8. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
Ozaydin E; Yükselgüngör H; Köse G
Eur J Paediatr Neurol; 2008 Mar; 12(2):141-3. PubMed ID: 17881258
[TBL] [Abstract][Full Text] [Related]
9. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
Velioğlu SK; Gazioğlu S
Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
[TBL] [Abstract][Full Text] [Related]
10. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
Masmoudi K; Gras-Champel V; Masson H; Andréjak M
Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
[TBL] [Abstract][Full Text] [Related]
11. Topiramate increases the risk of valproic acid-induced encephalopathy.
Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
[TBL] [Abstract][Full Text] [Related]
12. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Larsen EP; Ostergaard JR
Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
[TBL] [Abstract][Full Text] [Related]
13. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
14. [A case report of valproate encephalopathy].
Miyamoto T; Miyamoto M; Hirata K; Katayama S
Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
[TBL] [Abstract][Full Text] [Related]
15. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.
Guerrini R; Belmonte A; Canapicchi R; Casalini C; Perucca E
Epilepsia; 1998 Jan; 39(1):27-32. PubMed ID: 9578009
[TBL] [Abstract][Full Text] [Related]
16. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid induced hyperammonaemic encephalopathy.
Amanat S; Shahbaz N; Hassan Y
J Pak Med Assoc; 2013 Jan; 63(1):72-5. PubMed ID: 23865136
[TBL] [Abstract][Full Text] [Related]
18. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
Tsai MF; Chen CY
Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
[TBL] [Abstract][Full Text] [Related]
19. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
[TBL] [Abstract][Full Text] [Related]
20. Valproate-induced encephalopathy.
Chen WT; Yen DJ; Yu HY; Liao KK
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
